Properties (54)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Company
|
gptkbp:acquisition |
gptkb:InvaGen_Pharmaceuticals
Niche Generics |
gptkbp:awards |
Best Employer Brand 2021
Pharma_Company_of_the_Year_2020 Best_Corporate_Social_Responsibility_2020 |
gptkbp:CEO |
gptkb:Umang_Vohra
|
gptkbp:clinicalTrials |
conducts numerous annually
|
gptkbp:collaborations |
various NGOs
|
gptkbp:community_outreach |
awareness programs
health camps donations to health causes |
gptkbp:employeeCount |
over 25,000
|
gptkbp:financialPerformance |
investment in innovation
consistent growth dividend payments to shareholders |
gptkbp:focus |
affordable healthcare
|
gptkbp:founded |
1935
|
gptkbp:founder |
gptkb:Yusuf_Hamied
|
gptkbp:global_presence |
manufacturing facilities in multiple countries
distribution networks worldwide |
gptkbp:headquarters |
gptkb:Mumbai
|
https://www.w3.org/2000/01/rdf-schema#label |
Cipla
|
gptkbp:industry |
pharmaceuticals
|
gptkbp:market |
growing in emerging markets
significant_in_India |
gptkbp:mission |
to provide high-quality medicines at affordable prices.
|
gptkbp:operates_in |
over 80 countries
|
gptkbp:partnerships |
gptkb:Gilead_Sciences
with government agencies with healthcare providers with research institutions |
gptkbp:patentCitation |
holds several for innovative drugs
|
gptkbp:products |
generic drugs
|
gptkbp:research_areas |
HIV/AIDS
diabetes cardiology neurology oncology respiratory |
gptkbp:researchAndDevelopment |
significant investment
|
gptkbp:revenue |
$2.2 billion (2020)
|
gptkbp:social_responsibility |
support for local communities
commitment to affordable medicines healthcare_access_initiatives |
gptkbp:stockExchange |
gptkb:BSE
NSE |
gptkbp:sustainability_initiatives |
community health programs
environmental responsibility employee welfare programs |
gptkbp:training |
leadership development initiatives
continuous development programs technical skill enhancement |
gptkbp:vision |
to be a global leader in healthcare
|